In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis

Background: Mycobacterium abscessus pulmonary infection has recently emerged as a significant pathogen in patients with cystic fibrosis (CF) and is associated with significant morbidity and accelerated pulmonary decline. There is a paucity of data describing the activity of hospital biocides against...

Full description

Bibliographic Details
Main Authors: Steven Caskey, John E Moore, Jacqueline C Rendall
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=1;spage=45;epage=47;aulast=Caskey
_version_ 1828470310577373184
author Steven Caskey
John E Moore
Jacqueline C Rendall
author_facet Steven Caskey
John E Moore
Jacqueline C Rendall
author_sort Steven Caskey
collection DOAJ
description Background: Mycobacterium abscessus pulmonary infection has recently emerged as a significant pathogen in patients with cystic fibrosis (CF) and is associated with significant morbidity and accelerated pulmonary decline. There is a paucity of data describing the activity of hospital biocides against this organism. Methods: M. abscessus isolates (n = 13) were recovered from CF and non-CF respiratory specimens. Seven commonly employed hospital biocides with generic ingredients as follows: acetone, propan-2-ol, diethylene glycol, 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one, chlorine dioxide, 4% chlorhexidine, alcohol, and disodium carbonate, compound with hydrogen peroxide, 10% sodium hypochlorite were assayed for their biocidal activity against M. abscessus. Fresh cultures of M. abscessus were exposed to biocide in liquid medium as per manufacturers' instruction and were immediately plated following the completion of the contact period. The mean concentration of M. abscessus plated was 9.82 × 106 colony-forming units (range: 1.63 × 105–1.12 × 108). In addition, the remaining bacteria/biocide solution was enriched nonselectively in Mueller Hinton broth (37°C/1 week) and then plated. Results: All M. abscessus isolates survived in alkyl dimethyl benzyl ammonium chloride, 5-chloro-2-methyl-2H-isothiazol-3-one (EC No. 247-500-7) and 2-methyl-2H-isothiazol-3-one, 4% Chlorhexidine™, O-phenylphenol and Sodium Lauryl Sulfate™ and disodium carbonate, compound with hydrogen peroxide. One out of 13 M. abscessus cultures was killed by Chlorine Dioxide™ and one by Sodium Dichloroisocyanurate™, representing a 5-log kill. Two isolates were killed by Alcohol™ again representing a 5 log kill. Following enrichment, O-phenylphenol and Sodium Lauryl Sulfate™ showed the greatest biocidal activity with 11/13 isolates, whereas 2/13 cultures were killed by sodium dichloroisocyanurate™. All other biocide/culture combinations yielded growth. Conclusion: These data indicate that M. abscessus may persist after exposure to several common hospital biocides. Further work is urgently needed to define unequivocal biocide contact treatments to prevent cross-infection with this mycobacterial species in this patient population and thus ensure effective infection control and prevention.
first_indexed 2024-12-11T04:52:18Z
format Article
id doaj.art-3bce485b55d44a45a5969ee61621fdf4
institution Directory Open Access Journal
issn 2212-5531
2212-554X
language English
last_indexed 2024-12-11T04:52:18Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Mycobacteriology
spelling doaj.art-3bce485b55d44a45a5969ee61621fdf42022-12-22T01:20:22ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2018-01-0171454710.4103/ijmy.ijmy_197_17In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosisSteven CaskeyJohn E MooreJacqueline C RendallBackground: Mycobacterium abscessus pulmonary infection has recently emerged as a significant pathogen in patients with cystic fibrosis (CF) and is associated with significant morbidity and accelerated pulmonary decline. There is a paucity of data describing the activity of hospital biocides against this organism. Methods: M. abscessus isolates (n = 13) were recovered from CF and non-CF respiratory specimens. Seven commonly employed hospital biocides with generic ingredients as follows: acetone, propan-2-ol, diethylene glycol, 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one, chlorine dioxide, 4% chlorhexidine, alcohol, and disodium carbonate, compound with hydrogen peroxide, 10% sodium hypochlorite were assayed for their biocidal activity against M. abscessus. Fresh cultures of M. abscessus were exposed to biocide in liquid medium as per manufacturers' instruction and were immediately plated following the completion of the contact period. The mean concentration of M. abscessus plated was 9.82 × 106 colony-forming units (range: 1.63 × 105–1.12 × 108). In addition, the remaining bacteria/biocide solution was enriched nonselectively in Mueller Hinton broth (37°C/1 week) and then plated. Results: All M. abscessus isolates survived in alkyl dimethyl benzyl ammonium chloride, 5-chloro-2-methyl-2H-isothiazol-3-one (EC No. 247-500-7) and 2-methyl-2H-isothiazol-3-one, 4% Chlorhexidine™, O-phenylphenol and Sodium Lauryl Sulfate™ and disodium carbonate, compound with hydrogen peroxide. One out of 13 M. abscessus cultures was killed by Chlorine Dioxide™ and one by Sodium Dichloroisocyanurate™, representing a 5-log kill. Two isolates were killed by Alcohol™ again representing a 5 log kill. Following enrichment, O-phenylphenol and Sodium Lauryl Sulfate™ showed the greatest biocidal activity with 11/13 isolates, whereas 2/13 cultures were killed by sodium dichloroisocyanurate™. All other biocide/culture combinations yielded growth. Conclusion: These data indicate that M. abscessus may persist after exposure to several common hospital biocides. Further work is urgently needed to define unequivocal biocide contact treatments to prevent cross-infection with this mycobacterial species in this patient population and thus ensure effective infection control and prevention.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=1;spage=45;epage=47;aulast=CaskeyBiocidecystic fibrosisdisinfectionMycobacterium abscessusnontuberculous mycobacteria
spellingShingle Steven Caskey
John E Moore
Jacqueline C Rendall
In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis
International Journal of Mycobacteriology
Biocide
cystic fibrosis
disinfection
Mycobacterium abscessus
nontuberculous mycobacteria
title In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis
title_full In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis
title_fullStr In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis
title_full_unstemmed In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis
title_short In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis
title_sort in vitro activity of seven hospital biocides against mycobacterium abscessus implications for patients with cystic fibrosis
topic Biocide
cystic fibrosis
disinfection
Mycobacterium abscessus
nontuberculous mycobacteria
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=1;spage=45;epage=47;aulast=Caskey
work_keys_str_mv AT stevencaskey invitroactivityofsevenhospitalbiocidesagainstmycobacteriumabscessusimplicationsforpatientswithcysticfibrosis
AT johnemoore invitroactivityofsevenhospitalbiocidesagainstmycobacteriumabscessusimplicationsforpatientswithcysticfibrosis
AT jacquelinecrendall invitroactivityofsevenhospitalbiocidesagainstmycobacteriumabscessusimplicationsforpatientswithcysticfibrosis